Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches (Q39426072)

11 September 2017

Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches (English)

1 reference

11 September 2017

0 references

Arash Salmaninejad

1

0 references

author name string

Arezoo Gowhari

2

1 reference

11 September 2017

Seyedmojtaba Hosseini

3

1 reference

11 September 2017

Saeed Aslani

4

1 reference

11 September 2017

Meysam Yousefi

5

1 reference

11 September 2017

Tayyeb Bahrami

6

1 reference

11 September 2017

Masoume Ebrahimi

7

1 reference

11 September 2017

Abolfazl Nesaei

8

1 reference

11 September 2017

Masoud Zal

9

1 reference

11 September 2017

1 December 2017

1 reference

Journal of Immunotoxicology

11 September 2017

1 reference

11 September 2017

14

1 reference

11 September 2017

1

1 reference

11 September 2017

137-151

1 reference

Creative Commons Attribution 4.0 International

11 September 2017

start time

1 January 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pentoxifylline inhibits Vgamma9/Vdelta2 T lymphocyte activation of patients with active Behçets disease in vitro.

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Correlation of DEFA1 gene copy number variation with intestinal involvement in Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Renal Behçet's disease: a cumulative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Mucocutaneous lesions of Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Pentoxifylline for the treatment of anterior uveitis in Behcet's disease: possible alternative for TNF blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Prevalence of Behçet's disease in Istanbul, Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Vitamin D levels in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Immune regulation by glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Review of Systemic Immunosuppression for Autoimmune Uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Mesenchymal Stem Cells and Their Clinical Applications in Osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

New insights in the clinical understanding of Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Behcet's disease: from East to West.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

How to deal with Behcet's disease in daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Allogeneic mesenchymal stem cells: agents of immune modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Managing the symptoms of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Current concepts in the etiology and treatment of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Differentiation of Behcet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Mesenchymal Stromal Cell Therapy in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Genetic anticipation in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Pathogenesis of Behçet's disease: autoinflammatory features and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Familial aggregation of Behçet's disease in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Pulmonary artery aneurysms in Behçet syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Interleukin-33 and Behçet disease: Another cytokine among others

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Pentoxifylline and its applications in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

EULAR recommendations for the management of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Diagnosis and management of intestinal Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behçet's disease susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

IL18 polymorphism is associated with Behçet's disease but not lupus in patients from Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

MEFV gene is a probable susceptibility gene for Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Immunosuppression by mesenchymal stromal cells: from culture to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Genetic variation, classification and 'race'

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Genome-wide association study in an admixed case series reveals IL12A as a new candidate in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

The status of serum vitamin D in patients with active Behcet's disease compared with controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Epidemiology of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis--Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Pentoxifylline: a cheap substitute for anti-TNFalpha agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

The use of interferon alpha in Behçet disease: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Clinical aspects of vitamin D in the management of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

TNFAIP3 gene polymorphisms confer risk for Behcet's disease in a Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Azathioprine: old drug, new actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Behçet's disease as a systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Mechanisms of action of cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Behçet's disease--a contemporary review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Etiopathogenesis of Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Strong association of MIC-A*009 of extracellular domains and MIC-A*A6 of transmembrane domain in Korean patients with Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Close association of HLA-Bw51 with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Drug therapy in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Behçet disease: clinical features and management in a Brazilian tertiary hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Management of Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

New insights into the pathogenesis of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Clinical features of late-onset Behçet's disease: report of nine cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Gastrointestinal Behçet's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Etiopathology of Behçet's disease: herpes simplex virus infection and animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Cellular and molecular interactions of mesenchymal stem cells in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Genetic analysis of families of patients with Behçet's syndrome: data incompatible with autosomal recessive inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Familial autoinflammatory diseases: genetics, pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Detection of HSV-1 DNA in patients with Behcet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

NEMO mutation as a cause of familial occurrence of Behçet's disease in female patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

The immunogenetics of Behçet's disease: A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Novel therapies in vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

TNF polymorphisms in patients with Behçet disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

MIC-A allele profiles and HLA class I associations in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Novel genetic analysis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Thalidomide in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Dapsone in dermatology and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

IL10 polymorphisms associated with Behçet's disease in Chinese Han.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

FUT2: filling the gap between genes and environment in Behçet's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Immunological tolerance loss vs. erythrocyte self antigens and cytokine network disregulation in autoimmune hemolytic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

A controlled trial of azathioprine in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

A double-blind trial of colchicine in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Gastrointestinal involvement in Behçet's syndrome: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Mapping the HLA association in Behçet's disease: A role for tumor necrosis factor polymorphisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

Anakinra treatment in drug-resistant Behcet’s disease: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1547691X.2017.1346008

10.1080/1547691X.2017.1346008

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference